The CardioPostCovid Study: Cardiovascular Consequences After COVID-19
Trial Snapshot
- Phase
- Not Applicable
- Status
- Terminated
- Enrollment
- 80
- Locations
- 1
- Primary Endpoint
- Presence of at least one clinical, biological and/or imaging cardiovascular anomaly within 1 month of recovering
Study Overview
Brief Summary
The occurrence of cardiovascular complications in SARS-CoV-2 infections appears to be more frequent than in other viral respiratory infections, probably due to a singular pathophysiology of this coronavirus.
The lack of characterization of cardiovascular damages linked to Covid-19 could have medium and long-term consequences on the prognosis of patients. This problematic could lead to a second major public health problem linked to Covid-19 and it is therefore crucial to keep monitoring and screening patients at risk.
In this context of emerging infectious diseases, of poorly characterized cardiovascular damages during infection and of absence of data on the long-term evolution of the infection, the investigators propose to carry out a prospective and observational cohort study focused on the evaluation and the systematic cardiovascular follow up of patients who survived an episode of Covid-19, regardless of their cardiovascular profiles.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •All adults affiliated to social security attending the post-Covid follow-up consultation, having presented an episode of Covid-19 diagnosed by at least one positive nasopharyngeal RT-PCR test for SARS-Cov-2 and considered recovered.
Exclusion Criteria
- •Age <18 years old
- •Major under guardianship or curatorship
- •Absence of non-opposition
Outcomes
Primary Outcomes
Presence of at least one clinical, biological and/or imaging cardiovascular anomaly within 1 month of recovering
Time Frame: 1 month
Describe clinical, biological and imaging cardiovascular data 1 month after recovery from an episode of Covid-19
Secondary Outcomes
No secondary outcomes reported